
Company valuation, historical trends, and peer comparisons.
According to Transgene S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 208.85M. This represents a change of 50.14% compared to the average of 139.11M of the last 4 quarters.
The mean historical Enterprise Value of Transgene S.A. over the last ten years is 160.79M. The current 208.85M Enterprise Value has changed 29.89% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's Enterprise Value was at its highest in in the December 2009 quarter at 395.07M. The Enterprise Value was at its lowest in in the June 2008 quarter at 0.
Average
160.79M
Median
152.53M
Minimum
73.06M
Maximum
229.36M
Discovering the peaks and valleys of Transgene S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.35%
Maximum Annual Enterprise Value = 229.36M
Minimum Annual Increase = -40.84%
Minimum Annual Enterprise Value = 73.06M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 133.95M | 83.35% |
| 2024 | 73.06M | -40.84% |
| 2023 | 123.49M | -24.25% |
| 2022 | 163.02M | -28.92% |
| 2021 | 229.36M | 66.38% |
| 2020 | 137.86M | -2.95% |
| 2019 | 142.04M | -29.47% |
| 2018 | 201.38M | -6.74% |
| 2017 | 215.94M | 14.96% |
| 2016 | 187.84M | 44.82% |
The current Enterprise Value of Transgene S.A. (TRGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
110.17M
5-year avg
144.58M
10-year avg
160.79M
Transgene S.A.’s Enterprise Value is less than Hansa Biopharma AB (publ) (4.44B), less than Silence Therapeutics plc (863.29M), greater than Cellectis S.A. (132.72M), greater than Immutep Limited (-36877371.00), less than Genfit S.A. (622.84M), greater than hVIVO plc (38.45M), less than Santhera Pharmaceuticals Holding AG (232.09M), greater than Mayne Pharma Group Limited (182.87M), less than Probi AB (publ) (3.69B), greater than Oryzon Genomics S.A. (187.19M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.44B | $328.02M | |
| 863.29M | $923.91M | |
| 132.72M | $251.93M | |
| -36877371.00 | $29.47M | |
| 622.84M | $471.83M | |
| 38.45M | $54.25M | |
| 232.09M | $280.02M | |
| 182.87M | $153.14M | |
| 3.69B | $286.93M | |
| 187.19M | $253.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Transgene S.A.'s Enterprise Value?
What is the highest Enterprise Value for Transgene S.A. (TRGNF)?
What is the 3-year average Enterprise Value for Transgene S.A. (TRGNF)?
What is the 5-year average Enterprise Value for Transgene S.A. (TRGNF)?
How does the current Enterprise Value for Transgene S.A. (TRGNF) compare to its historical average?